The Effects of Combined Treatment with an HMG-CoA Reductase Inhibitor and PPARγ Agonist on the Activation of Rat Pancreatic Stellate Cells

Gut and Liver ◽

10.5009/gnl.2012.6.2.262 ◽

2012 ◽

Vol 6 (2) ◽

pp. 262-269 ◽

Author(s):

Beom Jae Lee ◽

Hong Sik Lee ◽

Chang Duck Kim ◽

Sung Woo Jung ◽

Yeon Seok Seo ◽

...

Keyword(s):

Reductase Inhibitor ◽

Combined Treatment ◽

Stellate Cells ◽

Pancreatic Stellate Cells ◽

Hmg Coa Reductase ◽

Pparγ Agonist ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

T1839 The Effects of Combination of HMG-CoA Reductase Inhibitor and PPARγ Agonist On Pancreatic Stellate Cells

Gastroenterology ◽

10.1016/s0016-5085(09)62720-7 ◽

2009 ◽

Vol 136 (5) ◽

pp. A-590

Author(s):

Beom Jae Lee ◽

Chang Duck Kim ◽

Jae Hong Ahn ◽

Jin Nam Kim ◽

Yong Dae Kwon ◽

...

Keyword(s):

Reductase Inhibitor ◽

Stellate Cells ◽

Pancreatic Stellate Cells ◽

Hmg Coa Reductase ◽

Pparγ Agonist ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

The effects of HMG-CoA reductase inhibitor on lipopolysaccharide induced activation of pancreatic stellate cells

Pancreatology ◽

10.1016/j.pan.2014.05.561 ◽

2014 ◽

Vol 14 (3) ◽

pp. S53-S54

Author(s):

Hong Sik Lee ◽

Jae Min Lee ◽

Jong Jin Hyun ◽

Hyo Jung Kim ◽

Jae Seon Kim ◽

...

Keyword(s):

Reductase Inhibitor ◽

Stellate Cells ◽

Pancreatic Stellate Cells ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Combined treatment of angiotensin receptor blocker and HMG-CoA reductase inhibitor synergistically improves cardiac dysfunction in Dahl rats

Journal of Molecular and Cellular Cardiology ◽

10.1016/j.yjmcc.2007.07.050 ◽

2008 ◽

Vol 44 (2) ◽

pp. 446-447

Author(s):

Yasuhiro Maejima ◽

Susumu Adachi ◽

Kazuya Isobe ◽

Hiroshi Ito ◽

Mitsuaki Isobe

Keyword(s):

Cardiac Dysfunction ◽

Reductase Inhibitor ◽

Angiotensin Receptor Blocker ◽

Combined Treatment ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Combined treatment with LDL-apheresis, chenodeoxycholic acid and HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosis

Journal of the Neurological Sciences ◽

10.1016/j.jns.2003.07.005 ◽

2003 ◽

Vol 216 (1) ◽

pp. 179-182 ◽

Author(s):

Shoichi Ito ◽

Satoshi Kuwabara ◽

Ryuji Sakakibara ◽

Takeshi Oki ◽

Hiroshi Arai ◽

...

Keyword(s):

Chenodeoxycholic Acid ◽

Reductase Inhibitor ◽

Combined Treatment ◽

Cerebrotendinous Xanthomatosis ◽

Ldl Apheresis ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Effect of Combined Treatment With an Angiotensin II Receptor Antagonist and an HMG-CoA Reductase Inhibitor on Atherosclerosis in Genetically Hyperlipidemic Rabbits

Journal of Cardiovascular Pharmacology ◽

10.1097/01.fjc.0000179434.18750.28 ◽

2005 ◽

Vol 46 (4) ◽

pp. 556-562 ◽

Author(s):

Mikio Kato ◽

Toshio Sada ◽

Makoto Mizuno ◽

Ken Kitayama ◽

Toshimori Inaba ◽

...

Keyword(s):

Angiotensin Ii ◽

Receptor Antagonist ◽

Reductase Inhibitor ◽

Combined Treatment ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Combined Treatment of HMG-CoA Reductase Inhibitor and Angiotensin Receptor Blocker Synergistically Inhibits Heart Failure in Dahl-salt Sensitive Rats

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2007.06.297 ◽

2007 ◽

Vol 13 (6) ◽

pp. S63

Author(s):

Yasuhiro Maejima ◽

Susumu Adachi ◽

Hiroshi Ito ◽

Mitsuaki Isobe

Keyword(s):

Heart Failure ◽

Reductase Inhibitor ◽

Angiotensin Receptor Blocker ◽

Combined Treatment ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

A Comparison of Continuous Combined Hormone Replacement Therapy, HMG-CoA Reductase Inhibitor and Combined Treatment for the Management of Hypercholesterolemia in Postmenopausal Women

Journal of Obstetrics and Gynaecology Research ◽

10.1111/j.1447-0756.2001.tb01285.x ◽

2001 ◽

Vol 27 (6) ◽

pp. 353-358 ◽

Author(s):

Serdar Ozsener ◽

Fatih Sendag ◽

Tayfun Koc ◽

Mustafa Cosan Terek ◽

Kemal Oztekin ◽

...

Keyword(s):

Hormone Replacement Therapy ◽

Replacement Therapy ◽

Postmenopausal Women ◽

Reductase Inhibitor ◽

Hormone Replacement ◽

Combined Treatment ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells

Oncology Reports ◽

10.3892/or.11.5.1053 ◽

2004 ◽

Author(s):

Takemi Otsuki ◽

Haruko Sakaguchi ◽

Tamayo Hatayama ◽

Tomohiro Fujii ◽

Takayuki Tsujioka ◽

...

Keyword(s):

Reductase Inhibitor ◽

Hmg Coa Reductase ◽

Myeloma Cells ◽

Hmg Coa Reductase Inhibitor ◽

Coa Reductase ◽

Human Myeloma Cells

Download Full-text

HMG-COA REDUCTASE INHIBITOR AFFECTS BLOOD PRESSURE AND VASCULAR REACTIVITY

Clinical and Experimental Pharmacology and Physiology ◽

10.1111/j.1440-1681.1995.tb02934.x ◽

1995 ◽

Vol 22 (s1) ◽

pp. S316-S317 ◽

Author(s):

N. Li ◽

M. Sawamura ◽

Y. Nara ◽

K. Kizawa ◽

K. Ikeda ◽

...

Keyword(s):

Blood Pressure ◽

Reductase Inhibitor ◽

Vascular Reactivity ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

Atherosclerosis ◽

10.1016/s0021-9150(01)00765-1 ◽

2002 ◽

Vol 163 (1) ◽

pp. 157-164 ◽

Author(s):

Yoshihiro Noji ◽

Toshinori Higashikata ◽

Akihiro Inazu ◽

Atsushi Nohara ◽

Kosei Ueda ◽

...

Keyword(s):

Familial Hypercholesterolemia ◽

Reductase Inhibitor ◽

Term Treatment ◽

Hmg Coa Reductase ◽

Heterozygous Familial Hypercholesterolemia ◽

Long Term Treatment ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text